WASHINGTON (dpa-AFX) - While reporting financial results for the fourth quarter on Wednesday, biopharmaceutical company AbbVie, Inc. (ABBV) initiated its adjusted earnings guidance for the full-year 2026, above analysts' estimates.
For fiscal 2026, AbbVie now projects adjusted earnings in a range of $14.37 to $14.57 per share, which excludes any impact from acquired IPR&D and milestones expense.
On average, 27 analysts polled expect the company to report earnings of $14.22 per share for the year. Analysts' estimates typically exclude special items.
For the fourth quarter, the company reported net earnings attributable to AbbVie of $1.82 billion or $1.02 per share, compared to $22 million or $0.02 per share in the prior-year quarter.
Excluding items, adjusted earnings for the quarter was $2.71 per share, compared to $2.16 per share in the year-ago quarter.
Net revenues for the quarter grew to $16.62 billion from $15.10 billion in the same quarter last year.
The Street was looking for earnings of $2.65 per share on revenues of $16.42 billion for the quarter.
In Wednesday's pre-market trading, ABBV is trading on the NYSE at $218.49, down $7.13 or 3.16 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Copyright(c) 2026 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2026 AFX News
